Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Iloprost for pulmonary arterial hypertension and right heart failure
2007-002803-42Phase 3Completed
- Sponsor
- Medical University of South Carolina
- Start
- Feb 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of iloprost in pulmonary arterial hypertension (PAH) and Right heart dysfunction (RHF), sponsored by Medical University of South Carolina. Primary endpoints: Change in cardiac output at 24 hours, Change in right atrial pressure at 24 hours and 5 more. Started Feb 2008; status: completed.
02
Drugs
iloprost
03
Conditions
pulmonary arterial hypertension (PAH)Right heart dysfunction (RHF)
Beyond the preview
Go deeper on 2007-002803-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002803-42.